Protego DF4 Post-Approval Registry
- Prospective, single-arm, non-randomized, multi-center registry
- To confirm long-term safety and reliability of BIOTRONIK's Protego DF4 lead, as used in conjunction with a BIOTRONIK DF4 compatible implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) pulse generator.
- 1,694 patients with an ICD or CRT-D implant at up to 75 centers in USA.
- This study is currently recruiting participants.
|Main Exclusion Criteria|